Oriza Seed Fund News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Oriza seed fund. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Oriza Seed Fund Today - Breaking & Trending Today

OnCusp Therapeutics Announces Appointment of Robert Forrester and Chau Khuong to Board of Directors

/PRNewswire/ OnCusp Therapeutics, a global biotechnology company with deep translational and clinical development expertise in oncology therapeutics, today. ....

New York , United States , City Of , United Kingdom , Brixton Biosciences , Chau Khuong , Robert Forrester , Yale University , Oriza Seed Fund , Bellus Health , Bristol University , Investment Group At Meespierson , Reviral Ltd , Cusp Therapeutics , Bing Yuan , Eyecool Therapeutics , Verastem Oncology , Forma Therapeutics , Affyimmune Therapeutics , Pillar Biosciences , Managing Director , Proprietary Investment Group , Oncusp Board , General Partner , Senior Advisor , Catalio Capital Management ,

OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies

Press release content from PR Newswire. The AP news staff was not involved in its creation.
OnCusp Therapeutics Commences Operations to Advance Innovative Oncology Therapies
June 30, 2021 GMT
NEW YORK, June 29, 2021 /PRNewswire/ OnCusp Therapeutics (or “OnCusp”), a global biopharmaceutical company focused on translating cutting-edge research assets into innovative oncology therapeutics, announced that it has officially commenced operations both in New York and Shanghai.
OnCusp successfully closed its seed round founding of $25 million on April 1, 2021, led by Sequoia Capital and Biotrack Capital, followed by Oriza Seed Fund and AIHC Capital. Proceeds from this round will be used to build a portfolio of innovative assets, advance research and development programs, as well as support the company’s day-to-day operations and talent acquisition. ....

New York , United States , Eric Slosberg , Lynn Yang , Daiichi Sankyo , Kevin Chen , Sandy Fu , Cstone Pharmaceuticals , World Health Organization , Oriza Seed Fund , International Agency For Research On Cancer , Global Head Of Oncology Translational Development , Sequoia Capital , Business Development , Cusp Therapeutics , Biotrack Capital , Bing Yuan , Chief Strategy , Business Officer , Chief Development Officer , Vice President , Global Head , Oncology Translational , Corporate Strategy , Founding Partner , Oncusp Therapeutic ,